Drug Trial Radar · NCT07728396
A Phase 1 Study to Evaluate the Safety and Immunogenicity of GC4006A in Healthy Adults
Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
72
Actual
Start
Jan 28, 2026
Primary completion
May 2027
Study completion May 2027
Sponsor
- Lead sponsor
- GC Biopharma CorpIndustry
- Sponsor type
- Industry
- First posted
- Jul 27, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 19 years, up to 64 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
A Phase 1, Randomized, Double-blind, Dose-Escalation, Placebo-Controlled, Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of the COVID-19 Preventive Vaccine 'GC4006A' in Healthy Adults Aged 19 to 64 Years
Conditions
- COVID - 19
Interventions
GC4006ABiological
administered as a single dose via Intramuscular injection.
Normal SalineDrug
Matching placebo administered as a single dose via Intramuscular injection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Solicited local and systemic AEsTime frame: From baseline up to 7 days
- Acute adverse eventsTime frame: From baseline up to 30 minutes
- Unsolicited adverse AEsTime frame: From baseline up to 28 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Korea University Guro Hospital
Seoul, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.